John Snisarenko
CIK 1783264 · Chief Commercial Officer · last filed 2024-09-18
John Snisarenko is a Chief Commercial Officer who has filed 13 SEC Form 4 insider transactions across 2 companies since 2019. Across all open-market trades the lifetime net is +$201.4K, making them a net buyer over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
2
13
$201.4K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ALIMERA SCIENCES INC (ALIM) Delisted | Director | 10,000 | $5.54 | $55.4K | $49.5K | 6 | 2023-10-04 |
| Oyster Point Pharma, Inc. (OYST) Delisted | Chief Commercial Officer | 30,322 | $11.17 | $338.7K | $151.9K | 6 | 2022-01-11 |
Recent Filings
13 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-09-18 | — | Disp (D) | −10,000 | $0 | |
| 2023-10-04 | ALIMERA SCIENCES INC (ALIM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-01-06 | ALIMERA SCIENCES INC (ALIM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-01-11 | Oyster Point Pharma, Inc. (OYST) Delisted | Grant (A) | +12,100 | $0 | EDGAR |
| 2021-11-04 | ALIMERA SCIENCES INC (ALIM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-09-24 | Oyster Point Pharma, Inc. (OYST) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-02-02 | Oyster Point Pharma, Inc. (OYST) Delisted | Grant (A) | +11,222 | $0 | EDGAR |
| 2020-08-11 | Oyster Point Pharma, Inc. (OYST) Delisted | Buy (P) | +4,000 | $103.9K | EDGAR |
| 2020-06-22 | ALIMERA SCIENCES INC (ALIM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-02-05 | Oyster Point Pharma, Inc. (OYST) Delisted | Grant (A) | — | $0 | EDGAR |